How Often Does the Fecal Test for Occult Blood Turn Positive After Using Blood Thinners?
NCT07327853 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2026-01-08
Summary
Blood thinner medications used for cardiovascular disease can cause gastrointestinal bleeding. Early detection of invisible bleeding by performing occult fecal blood test (called fecal immunochemical test, or FIT) can uncover serious disease in the stomach and intestine and enable the treating physician to refer the patient for further evaluation.
Conditions
- Gastrointestinal Bleeding
- Antiplatelet Agents
- Oral Anticoagulant Therapy
Interventions
- DIAGNOSTIC_TEST
-
Fecal Immunochemical Test (FIT)
A stool sample will be tested by the FIT test to examine the presence or absence of fecal occult blood. Each participant will be tested twice; one before starting the oral antiplatelet or anticoagulant agents and the second 3 months after the use of the medication.
Sponsors & Collaborators
-
Jordan Collaborating Cardiology Group
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-02-01
- Primary Completion
- 2026-12-31
- Completion
- 2027-04-30
Countries
- Jordan
Study Locations
More Related Trials
-
Intensive Statin Therapy in Patients With AMI
NCT01923077 ·Status: UNKNOWN ·Phase: PHASE2
-
Cholesterol and Statin in Healthy Adults
NCT02908425 ·Status: COMPLETED ·Phase: NA
-
Intensive Statin Therapy in PCI Patient With Acute Coronary Syndrome
NCT01372839 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Acute Statin Treatment in Patients Undergoing Percutaneous Coronary Intervention
NCT00588471 ·Status: TERMINATED ·Phase: NA
-
Protective Effect of Early High Dose stATins On Cardiovascular and Renal Events in Acute Coronary Syndrome
NCT04087200 ·Status: RECRUITING
-
Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression (SEARCH)
NCT06922994 ·Status: RECRUITING ·Phase: PHASE2
-
Drug Interaction Study of Simvastatin and Dabigatran
NCT03728101 ·Status: COMPLETED ·Phase: PHASE1
-
Statin and Post-interventional Coronary Microcirculation Dysfunction
NCT01751295 ·Status: UNKNOWN ·Phase: NA
-
Optimal LDL-C Target in High-risk Patients After PCI
NCT06821711 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect of Statins on Oxidative Stress and Endothelial Progenitor Cells
NCT00166036 ·Status: COMPLETED ·Phase: PHASE2
-
Short Term Statin Treatment and Endothelial Dysfunction Due to Ischemia and Reperfusion Injury
NCT00987974 ·Status: COMPLETED ·Phase: PHASE4
-
Anti-inflammatory Effects of Colchicine in PCI
NCT01709981 ·Status: COMPLETED ·Phase: PHASE4
-
High Dose and Low Dose of Atorvastatin in Patients With Unstable Angina and NSTEMI (Non ST Elevation MI)
NCT01306565 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Statins on Lipid Goal Attainment and Lipid Parameters in PCI Patients
NCT02561845 ·Status: WITHDRAWN
-
Intensive Statin Treatment in Chinese Coronary Artery Disease Patients Undergoing PCI
NCT01293097 ·Status: COMPLETED ·Phase: PHASE4
-
Longitudinal Study of Multi-Analyte Profile for Dyslipidemia
NCT01441908 ·Status: UNKNOWN ·Phase: NA
-
Statin and Angiotensin-converting Enzyme Inhibitor on Symptoms in Patients With SCAD
NCT02008786 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of Statin Mechanism Preventing Cardiovascular Disease by Post-hoc Analysis of Treating to New Targets Study
NCT03073863 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of UDCA on the New Onset Diabetes and Glucose Intolerance Induced by Statin
NCT05500937 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Efficacy of High Dose atorvaSTATIN Loading Before Primary Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction (STATIN STEMI)
NCT00808717 ·Status: COMPLETED ·Phase: PHASE4
-
Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography
NCT06863545 ·Status: RECRUITING ·Phase: NA
-
Reverse Cholesterol Transport (RCT) Study
NCT01031758 ·Status: COMPLETED ·Phase: NA
-
Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event
NCT03988101 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Atorvastatin on Prevention of Postoperative Acute Kidney Injury in Patients Undergoing Aortic Surgery
NCT02157337 ·Status: COMPLETED ·Phase: PHASE4
-
Nattokinase Atherothrombotic Prevention Study
NCT02080520 ·Status: COMPLETED ·Phase: NA